Free Trial
NASDAQ:AMPH

Amphastar Pharmaceuticals (AMPH) Stock Price, News & Analysis

Amphastar Pharmaceuticals logo
$22.21 -0.23 (-1.02%)
Closing price 04:00 PM Eastern
Extended Trading
$22.21 0.00 (0.00%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Amphastar Pharmaceuticals Stock (NASDAQ:AMPH)

Key Stats

Today's Range
$22.20
$22.83
50-Day Range
$22.44
$26.92
52-Week Range
$22.21
$53.96
Volume
464,402 shs
Average Volume
496,020 shs
Market Capitalization
$1.05 billion
P/E Ratio
8.05
Dividend Yield
N/A
Price Target
$32.33
Consensus Rating
Hold

Company Overview

Amphastar Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
89th Percentile Overall Score

AMPH MarketRank™: 

Amphastar Pharmaceuticals scored higher than 89% of companies evaluated by MarketBeat, and ranked 128th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Amphastar Pharmaceuticals has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 1 buy rating, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Amphastar Pharmaceuticals has only been the subject of 2 research reports in the past 90 days.

  • Read more about Amphastar Pharmaceuticals' stock forecast and price target.
  • Earnings Growth

    Earnings for Amphastar Pharmaceuticals are expected to decrease by -5.73% in the coming year, from $3.49 to $3.29 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Amphastar Pharmaceuticals is 8.05, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.68.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Amphastar Pharmaceuticals is 8.05, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.20.

  • Price to Earnings Growth Ratio

    Amphastar Pharmaceuticals has a PEG Ratio of 5.89. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Amphastar Pharmaceuticals has a P/B Ratio of 1.46. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Amphastar Pharmaceuticals' valuation and earnings.
  • Percentage of Shares Shorted

    11.80% of the float of Amphastar Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Amphastar Pharmaceuticals has a short interest ratio ("days to cover") of 7.3.
  • Change versus previous month

    Short interest in Amphastar Pharmaceuticals has recently decreased by 0.49%, indicating that investor sentiment is improving.
  • Dividend Yield

    Amphastar Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    Amphastar Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    11.80% of the float of Amphastar Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Amphastar Pharmaceuticals has a short interest ratio ("days to cover") of 7.3.
  • Change versus previous month

    Short interest in Amphastar Pharmaceuticals has recently decreased by 0.49%, indicating that investor sentiment is improving.
  • News Sentiment

    Amphastar Pharmaceuticals has a news sentiment score of 0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Amphastar Pharmaceuticals this week, compared to 4 articles on an average week.
  • Search Interest

    4 people have searched for AMPH on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Amphastar Pharmaceuticals insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $36,610.00 in company stock.

  • Percentage Held by Insiders

    27.50% of the stock of Amphastar Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    65.09% of the stock of Amphastar Pharmaceuticals is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Amphastar Pharmaceuticals' insider trading history.
Receive AMPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amphastar Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AMPH Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
AMPH Amphastar Pharmaceuticals, Inc. - Seeking Alpha
Amphastar Pharmaceuticals Inc.DL-Exchang. Notes 2023(29) Bond
Amphastar Pharmaceuticals, Inc. (AMPH) - Yahoo Finance
See More Headlines

AMPH Stock Analysis - Frequently Asked Questions

Amphastar Pharmaceuticals' stock was trading at $37.13 at the beginning of 2025. Since then, AMPH stock has decreased by 40.2% and is now trading at $22.21.

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) issued its quarterly earnings data on Monday, November, 8th. The company reported $0.46 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.22. The business had revenue of $112.20 million for the quarter, compared to analyst estimates of $103 million. Amphastar Pharmaceuticals had a trailing twelve-month return on equity of 22.20% and a net margin of 19.38%.
Read the conference call transcript
.

Top institutional shareholders of Amphastar Pharmaceuticals include MassMutual Private Wealth & Trust FSB. Insiders that own company stock include Mary Z Luo, Howard Lee, Rong Zhou, William J Peters, Floyd F Petersen, Yakob Liawatidewi, Richard K Prins, Michael A Zasloff and Diane G Gerst.
View institutional ownership trends
.

Shares of AMPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Amphastar Pharmaceuticals investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Meta Platforms (META), ServiceNow (NOW), Novo Nordisk A/S (NVO) and e.l.f. Beauty (ELF).

Company Calendar

Last Earnings
11/08/2021
Today
7/10/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - GENERIC DRG
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:AMPH
CIK
1297184
Employees
2,028
Year Founded
N/A

Price Target and Rating

High Price Target
$35.00
Low Price Target
$30.00
Potential Upside/Downside
+43.5%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
$2.76
Trailing P/E Ratio
8.19
Forward P/E Ratio
6.46
P/E Growth
5.89
Net Income
$159.52 million
Net Margins
19.38%
Pretax Margin
23.64%
Return on Equity
22.20%
Return on Assets
10.40%

Debt

Debt-to-Equity Ratio
0.80
Current Ratio
2.95
Quick Ratio
2.02

Sales & Book Value

Annual Sales
$731.97 million
Price / Sales
1.45
Cash Flow
$4.99 per share
Price / Cash Flow
4.52
Book Value
$15.23 per share
Price / Book
1.48

Miscellaneous

Outstanding Shares
47,140,000
Free Float
34,176,000
Market Cap
$1.06 billion
Optionable
Optionable
Beta
0.72

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:AMPH) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners